Frank Pallone actually said...

I look forward to working with my colleagues in a bipartisan way to ensure that promising new medicines get to patients in a timely manner, ...

If we are going to have a comprehensive discussion about how to promote innovation and medical advancements, we can't simply focus on the FD...

I would encourage them to do what they can to support that.

the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respon...